Applied Evidence

Diabetes in the elderly: Matching meds to needs

Author and Disclosure Information

 

From The Journal of Family Practice | 2018;67(7):408-410,412-415.

References

Combining antidiabetes agents

Combination therapy is often needed as T2DM progresses, even though strict glucose control is generally not recommended for the elderly.31 The American Geriatrics Society advises avoiding additional medications other than metformin to achieve an A1C level below 7.5% in most older adults.

However, for older patients already taking metformin who are not at their A1C goal, consider adding a second agent, if not contraindicated. Potential agents include a GLP-1 RA, SGLT-2 inhibitor, DDP-4 inhibitor, or short-acting sulfonylurea (glipizide). Alternatively, basal insulin may be added. However, avoid combining a sulfonylurea with insulin, which greatly increases the risk of hypoglycemia.32 Consider adding a GLP-1 RA or basal insulin if the patient is not at his/her target A1C on oral therapy with multiple agents.3

CORRESPONDENCE
Barbara Keber, MD, Glen Cove Hospital, 101 St. Andrews Lane, Glen Cove, NY; bkeber@northwell.edu.

Pages

Recommended Reading

EMR-Based Tool for Identifying Type 2 Diabetic Patients at High Risk for Hypoglycemia
Journal of Clinical Outcomes Management
Approaches to Enhancing Patient-Centered Communication In Caring For Hispanic/Latino Patients With Diabetes
Journal of Clinical Outcomes Management
Medical associations fight American College of Physicians HBA1c recommendations
Journal of Clinical Outcomes Management
Guidelines May Help Reduce Stroke Risk in Patients With Diabetes
Journal of Clinical Outcomes Management
ACP issues 4 statements on T2DM treatment targets
Journal of Clinical Outcomes Management
Multidisciplinary Diabetes Care in a Safety Net Clinic: Lessons Learned from a Quality Improvement Initiative
Journal of Clinical Outcomes Management
Commentary: Shifting the care delivery paradigm to diabetes-depression collaborative care models
Journal of Clinical Outcomes Management
The case for bariatric surgery to manage CV risk in diabetes
Journal of Clinical Outcomes Management
Type 2 diabetes may promote Parkinson development
Journal of Clinical Outcomes Management
Intensive treatment for T2D pays off in the long run
Journal of Clinical Outcomes Management